RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

172 hedge funds and large institutions have $2.79B invested in Ultragenyx Pharmaceutical in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 56 reducing their positions, and 15 closing their positions.

Holders
172
Holders Change
+11
Holders Change %
+6.83%
% of All Funds
4.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
67
Reduced
56
Closed
15
Calls
$14.3M
Puts
$6.15M
Net Calls
+$8.14M
Net Calls Change
+$9.02M

Top Buyers

1
CGT
1
Capital Guardian Trust
California
$35M
2
Capital International Investors
2
Capital International Investors
California
$34.1M
3
CWAM
3
Columbia Wanger Asset Management
Illinois
$89.2M
4
EA
4
Emerald Advisers
Pennsylvania
$19.2M
5
EMFAT
5
Emerald Mutual Fund Advisers Trust
Pennsylvania
$18.8M

Top Sellers

1
Wells Fargo
1
Wells Fargo
California
$52.2M
2
Millennium Management
2
Millennium Management
New York
$709K
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$11.2M
4
Ameriprise
4
Ameriprise
Minnesota
$12.3M
5
WC
5
Weatherbie Capital
Massachusetts
$16.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
PP
176
Paloma Partners
Connecticut
– -$362K -7,398 Closed
HCM
177
Highbridge Capital Management
New York
– -$357K -7,304 Closed
AIM
178
Assured Investment Management
New York
– -$331K -6,770 Closed
AQR Capital Management
179
AQR Capital Management
Connecticut
– -$314K -6,419 Closed
CPIM
180
Columbia Partners Investment Management
Virginia
– -$287K -5,882 Closed
DTL
181
Dynamic Technology Lab
Singapore
– -$225K -4,606 Closed
US Bancorp
182
US Bancorp
Minnesota
– -$34K -693 Closed
PNC Financial Services Group
183
PNC Financial Services Group
Pennsylvania
– -$10K -200 Closed
4 5 6 7
8